John M. Kane

Roswell Park Comprehensive Cancer Center

Also affiliated with Northwell Health, Feinstein Institute for Medical Research, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, Institute of Behavioral Sciences, Zucker Hillside Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “NRG-DT001 phase Ib trial of neoadjuvant navtemadlin (previously AMG232 and KRT232) concurrent with preoperative radiotherapy in wild-type p53 soft tissue sarcoma of the extremity and body wall.”.

NRG-DT001 phase Ib trial of neoadjuvant navtemadlin (previously AMG232 and KRT232) concurrent with preoperative radiotherapy in wild-type p53 soft tissue sarcoma of the extremity and body wall.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.11521

N/A

0DataRank · unranked

2 citations

Pedro A. Torres‐Saavedra, Brian Andrew Van Tine, David G. Kirsch, Michelle A. Rudek, Paul E. Wakely +13 more

Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma

Annals of Surgical Oncology(2023)10.1245/s10434-023-13570-9

N/A

0DataRank · unranked

1 citations

John Hyngstrom, Corrado Caracò, Jonathan S. Zager, Tiina Jahkola, Tawnya L. Bowles +42 more